drugset / Trial / NCT04371523

Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers

NCT04371523

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The objectives of PROVIDE are to: 1. Determine if prophylactic once weekly hydroxychloroquine reduces the incidence of conversion from SARS-2-CoVnasopharyngeal swab negative to positive 2. To determine if weekly prophylactic hydroxychloroquine reduced the severity of COVID-19 symptoms 3. To determine the safety of taking weekly prophylactic hydroxychloroquine

Timeline

Start
2020-05-01
Primary completion
2020-07-31
Completion
2020-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydroxychloroquine Small molecule 400 mg Oral

Indications